You are hereAbout
C2E2 Annual Lecture 2016 Guest Speaker: Professor Timothy Caulfield+
A Losing Battle? Health Science in the Age of Celebrity
There is a ridiculous amount of science-free health and wellness advice floating around in popular culture. And much of this information is conflicting, misleading or just plain crazy. In this provocative presentation Professor Caulfield will explore why and how health information gets so twisted, including the increasingly important role of celebrity culture. He will also review why this matters (and it does!) and how it impacts our health and health policy.
C2E2’s Boris Sobolev to speak at Bayesia Conference in Nashville+
Dr. Boris Sobolev will be a Plenary Speaker at the 4th Annual Bayesia Lab Conference held September 25 – October 2 in Nashville, Tennessee. The conference focuses on applied research with Bayesian networks and provides opportunity to learn about the latest methodologies and best practices.
Dr. Sobolev’s talk “Causal attribution of mortality to delays in heart surgery” will discuss causal attribution of reduction in postoperative mortality to timing of cardiac surgery using observations collected in a population-based cardiac registry.
Congratulations! Dr. Mohsen Sadatsafavi and Dr. Lindsay Hedden receive MSFHR awards+
Recently, the Michael Smith Foundation for Health Research (MSFHR) recognized the work of two C2E2 researchers, Dr. Mohsen Sadatsafavi and Dr. Lindsay Hedden.
C2E2's Nick Bansback and Asif Khowaja award winners at CADTH Conference
Nick Bansback (pictured, second from right)+
Nick Bansback (pictured, second from right)
The Centre for Clinical Epidemiology and Evaluation is pleased to announce that Dr. Nick Bansback has been selected by CADTH as the 2016 recipient of the Maurice McGregor Award, an award that recognizes rising stars in the field of health technology assessment early in their careers.
New project shines spotlight on rare diseases+
It’s fitting that this year’s Rare Disease Day falls on a day that only comes around every four years. This leap day, Feb. 29, UBC researchers will launch a project to raise awareness about rare diseases and the issues facing patients and policy makers here in Canada.
Vancouver Stroke Study to use Hyperbaric Chamber+
VGH seeking stroke survivors for North America’s first of its kind hyperbaric oxygen study
A multidisciplinary team at Vancouver General Hospital (VGH) will be the first in North America to study the role that hyperbaric oxygen therapy could play in improving neurological function in recovering stroke patients. The group includes scientists Craig Mitton and Penny Brasher from C2E2 and associate scientist, Riyad Abu-Laban.
Boundary-spanning in academic healthcare organisations+
C2E2's Post-doctoral fellow, Bryn Lander, has had her article "Boundary-spanning in Academic Healthcare Organizations" published in the journal Research Policy
Common anti-depressant linked to health risk during childbirth+
Women taking a common type of antidepressant drug face a significantly higher risk of excessive bleeding after giving birth, according to research by the UBC Faculty of Medicine.
Using health records of women who gave birth in British Columbia between 2002 and 2011, the researchers found that use of selective serotonin-norepinephrine reuptake inhibitors (SNRIs) in the last month of pregnancy increased the likelihood of postpartum hemorrhage by 1.6 times, compared to those not taking SNRIs. Postpartum hemorrhage is a major cause of complications during childbirth.
C2E2 Rounds are presented Mondays from 12:00 pm to 1:00 pm in room 700 of the VGH Research Pavilion, 828 West 10th Avenue, Vancouver, BC.
Oct 22, 2018 // Sylvia Struck
Oct 29, 2018 // Stephanie Harvard
Nov 5, 2018 // Boris Sobolev & Lisa Kuramoto